Our AI instantly delivers powerful, actionable diabetes insights from one of the world’s richest diabetes datasets.
Our research found that diabetes keeps many awake at night due to symptoms, complications, and comorbidities of diabetes.
We looked back at the 10-year trends in diabetes drug and device penetration in the dQ&A Community—here's what we found.
Our quarterly U.S. survey shows diabetes sharply reduces productivity and daily-life capacity—evidence that employers must offer stronger support.
From a son’s T1D diagnosis to thousands of focus groups and ethnographies, discover the journey behind dQ&A’s qualitative insights service.
Since day one, dQ&A has elevated diabetes patient voices—explore our infographic to see how these insights have shaped client decisions over the years.
Our quarterly U.S. diabetes survey found one-third of respondents had mild or severe depression, underscoring the need for more support and better treatments.
Erik Shoger presented real-world patient insights at the FDA advisory meeting on sotagliflozin, highlighting the need for education and training if approved.
We invite you to watch this 4-minute selfie video reel featuring real people describing their very real struggles with diabetes.
